Kothari Fermentation & Biochem Intrinsic Value
Kothari Fermentation & Biochem (KFBL) median intrinsic value is ₹59.73 from 4 valuation models (range ₹28–₹68), vs current price ₹45.23 — +32.1% upside (Trading Below Calculated Value), margin of safety 24.3%. Analyse KFBL promoter holding to track promoter, FII and institutional holdings.
KFBL Valuation Methods Summary — DCF, Graham Number & P/E
Kothari Fermentation & Biochem intrinsic value across 4 models vs current price ₹45.23 — upside/downside and value range per method. Read Kothari Fermentation & Biochem dividend policy for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹36.00 | ₹32.40 - ₹39.60 | -20.4% | Book Value/Share: ₹36.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹59.73 | ₹53.76 - ₹65.70 | +32.1% | Revenue/Share: ₹74.67, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹28.00 | ₹25.20 - ₹30.80 | -38.1% | EBITDA: ₹7.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹68.08 | ₹54.46 - ₹81.70 | +50.5% | CF Growth: 5.0%, Discount: 15% |
KFBL Intrinsic Value vs Market Price — All Valuation Models
Kothari Fermentation & Biochem fair value range ₹28–₹68 vs current market price ₹45.23 across 4 valuation models. For current market price and key ratios, visit Kothari Fermentation & Biochem share price screener.
KFBL Intrinsic Value Analysis — Undervalued or Overvalued?
Kothari Fermentation & Biochem median intrinsic value ₹59.73, current price ₹45.23 — Trading Below Calculated Value by 32.1%, margin of safety 24.3%.
What is the intrinsic value of KFBL?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Kothari Fermentation & Biochem (KFBL) is ₹59.73 (median value). With the current market price of ₹45.23, this represents a +32.1% variance from our estimated fair value.
The valuation range spans from ₹28.00 to ₹68.08, indicating ₹28.00 - ₹68.08.
Is KFBL undervalued or overvalued?
Based on our multi-method analysis, Kothari Fermentation & Biochem (KFBL) appears to be trading below calculated value by approximately 32.1%.
KFBL Financial Health — Key Ratios vs Industry Benchmarks
Kothari Fermentation & Biochem financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.62 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | -5.6% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 6.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.88x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
KFBL Cash Flow Quality — Operating & Free Cash Flow
Kothari Fermentation & Biochem operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹11 Cr | ₹9 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹9 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹6 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹10 Cr | ₹4 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹15 Cr | ₹7 Cr | Positive Free Cash Flow | 7/10 |